Delivery Order SPE2DB22D2006-SPE2DB24FV7XU
Award Date
2/3/24
Potential Completion Date
2/5/24
Potential Value
$5.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,288.04 firm fixed-price delivery order covers the supply of NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, a pharmaceutical product, with a performance period through November 2024. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,051.68 and a completion date of June 13, 2025. The award is for the supply of the drug NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, a pharmaceutical product. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NAROPIN 0.2% 40 MG/20 ML VIAL 20ML, a medical product, with a ceiling value of $1,903.47 and a performance period ending on January 14, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $1,406.70 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the supply of NAROPIN 0.5% 100 MG/20 ML VIAL 20ML, a prescription pharmaceutical product. The award has an ultimate completion date of May 29, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,291.53 firm fixed-price delivery order is for the supply of NAROPIN 0.5% 100 MG/20 ML VIAL 20ML, a medical product. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,801.63 firm fixed-price delivery order is for the supply of NAROPIN 0.5% 100 MG/20 ML VIAL 20ML, a specialty medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of NAROPIN 0.2% 400 MG/200 ML BTL 200ML pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is a subsidiary of Cencora, Inc. The contract, valued at $5,214.94, was awarded on September 21, 2022, with a completion date of September 22, 2022. It is a delivery order contract with a firm fixed price pricing type. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,361.71 firm fixed-price delivery order covers the supply of NAROPIN 0.2% 400 MG/200 ML BTL 200ML, a specialty pharmaceutical product, with a performance period ending on August 30, 2022. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $4,398.46 order is for 4564184800 units of the pharmaceutical product Naropin 0.5%, 150 mg/30 mL vials. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,402.91 contract provides the DLA with 30 ml vials of the anesthetic medication Naropin 0.5%. The award is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which supplies a wide range of pharmaceutical and medical products to support...